A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer.
Christos VaklavasErica M Stringer-ReasorAhmed M ElkhananyKevin J RyanYufeng LiCharles P TheuerEdward P AcostaShi WeiEddy Shih-Hsin YangWilliam E GrizzleAndres Forero-TorresPublished in: Breast cancer research and treatment (2023)
This trial is registered with ClinicalTrials.gov (Identifier: NCT02520063), first posted on August 11, 2015, and is active, not recruiting.